US Stock MarketDetailed Quotes
PETS PetMed Express
- 3.978
- +0.008+0.20%
Trading Oct 18 11:23 ET
81.95MMarket Cap-30600P/E (TTM)
4.010High3.925Low37.43KVolume3.960Open3.970Pre Close148.63KTurnover0.22%Turnover RatioLossP/E (Static)20.60MShares10.53052wk High0.88P/B67.25MFloat Cap2.90052wk Low0.30Dividend TTM16.91MShs Float48.951Historical High7.54%Div YieldTTM2.14%Amplitude0.047Historical Low3.971Avg Price1Lot Size
PetMed Express Key Stats
Quarterly+Annual
YOY
| (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -1,615.48%-8.52M | -84.47%4.32M | -26.72%7.13M | -120.00%-2.59M | 38.92%-777K | -91.19%562K | 50.30%27.8M | 11.55%9.72M | 48.99%12.97M | -184.97%-1.27M |
| Net income from continuing operations | 430.46%3.75M | -245.21%-7.46M | -2,222.22%-5.02M | -74,650.00%-1.49M | -93.29%179K | -142.28%-1.14M | -72.54%5.14M | -105.87%-216K | -99.95%2K | -57.99%2.67M |
| Depreciation and amortization | 2.56%1.72M | 98.98%7.06M | 90.64%1.9M | 88.10%1.77M | 99.65%1.71M | 122.84%1.68M | 29.51%3.55M | 44.69%994K | 32.54%941K | 23.63%858K |
| Deferred tax | 95.85%-26K | 117.91%292K | 241.09%728K | 51.03%-355K | 41.09%546K | 19.20%-627K | -92.67%-1.63M | 37.61%-516K | -98.63%-725K | -24.56%387K |
| Change In working capital | -421.55%-5.9M | -119.83%-2.76M | -4.24%7.58M | -139.43%-4.24M | 27.96%-4.96M | -153.02%-1.13M | 303.93%13.92M | 119.42%7.91M | 310.89%10.76M | 1.21%-6.89M |
| -Change in receivables | 2,013.04%880K | -4,148.78%-1.74M | -673.50%-1.62M | 138.90%226K | -274.85%-299K | -153.49%-46K | -108.06%-41K | 140.03%283K | -207.39%-581K | -38.71%171K |
| -Change in inventory | 129.81%3.04M | -147.77%-6.42M | 78.19%6.02M | -234.90%-15.68M | 217.25%13.42M | -203.09%-10.19M | 583.56%13.43M | 170.18%3.38M | 246.96%11.62M | -221.25%-11.45M |
| -Change in prepaid assets | 229.54%2.66M | 1,500.00%490K | 85.75%3.09M | 141.36%491K | 37.01%-1.04M | -281.54%-2.06M | 58.82%-35K | 460.74%1.66M | -665.24%-1.19M | -33.04%-1.64M |
| -Change in payables and accrued expense | -210.24%-12.03M | 842.32%5.28M | -78.80%548K | 1,139.12%11.21M | -388.33%-17.4M | 221.72%10.91M | 106.08%560K | -73.04%2.59M | -90.74%905K | 139.04%6.03M |
| -Change in other current assets | -31.12%135K | --788K | --194K | --200K | --198K | --196K | --0 | --0 | --0 | --0 |
| -Change in other current liabilities | 35.12%-133K | ---766K | ---189K | ---194K | ---178K | ---205K | --0 | --0 | --0 | --0 |
| -Change in other working capital | -280.63%-457K | ---390K | ---465K | ---504K | --326K | --253K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -1,615.48%-8.52M | -84.47%4.32M | -26.73%7.13M | -119.99%-2.59M | 38.92%-777K | -91.19%562K | 50.30%27.8M | 11.55%9.72M | 48.99%12.97M | -184.97%-1.27M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 98.15%-683K | -296.39%-40.67M | 35.21%-1.25M | -43.30%-1.42M | 27.33%-984K | -518.72%-37.01M | -485.62%-10.26M | -297.33%-1.93M | -237.76%-993K | -173.54%-1.35M |
| Net PPE purchase and sale | 40.76%-683K | 14.24%-4.51M | 35.21%-1.25M | -13.09%-1.12M | 27.33%-984K | -17.41%-1.15M | -200.23%-5.26M | -297.33%-1.93M | -237.76%-993K | -173.54%-1.35M |
| Net business purchase and sale | --0 | -623.18%-36.16M | --0 | ---300K | --0 | -617.18%-35.86M | ---5M | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 98.15%-683K | -296.39%-40.67M | 35.21%-1.25M | -43.30%-1.42M | 27.33%-984K | -518.72%-37.01M | -485.62%-10.26M | -297.33%-1.93M | -237.76%-993K | -173.54%-1.35M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 98.30%-104K | 49.31%-12.44M | 99.71%-18K | 99.75%-15K | -0.96%-6.3M | -0.63%-6.1M | -0.63%-24.54M | -1.20%-6.14M | -0.54%-6.1M | -0.26%-6.24M |
| Cash dividends paid | 98.30%-104K | 49.31%-12.44M | 99.71%-18K | 99.75%-15K | -0.96%-6.3M | -0.63%-6.1M | -0.63%-24.54M | -1.20%-6.14M | -0.54%-6.1M | -0.26%-6.24M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 98.30%-104K | 49.31%-12.44M | 99.71%-18K | 99.75%-15K | -0.96%-6.3M | -0.63%-6.1M | -0.63%-24.54M | -1.20%-6.14M | -0.54%-6.1M | -0.26%-6.24M |
| Net cash flow | ||||||||||
| Beginning cash position | -46.87%55.3M | -6.30%104.09M | -51.73%49.44M | -44.62%53.47M | -41.63%61.53M | -6.30%104.09M | -6.43%111.08M | -5.95%102.43M | -9.40%96.55M | -5.70%105.41M |
| Current changes in cash | 78.13%-9.3M | -597.60%-48.79M | 253.20%5.86M | -168.53%-4.03M | 9.08%-8.06M | -651.01%-42.55M | 8.43%-6.99M | -23.56%1.66M | 150.40%5.88M | -69.75%-8.87M |
| End cash Position | -25.26%45.99M | -46.87%55.3M | -46.87%55.3M | -51.73%49.44M | -44.62%53.47M | -41.63%61.53M | -6.30%104.09M | -6.30%104.09M | -5.95%102.43M | -9.40%96.55M |
| Free cash flow | -1,456.68%-9.2M | -100.86%-194K | -24.62%5.87M | -131.02%-3.72M | 32.94%-1.76M | -110.95%-591K | 34.62%22.54M | -5.32%7.79M | 42.39%11.98M | -362.08%-2.63M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data